These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 2054233

  • 21. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
    Eelen G, Verlinden L, van Camp M, van Hummelen P, Marchal K, de Moor B, Mathieu C, Carmeliet G, Bouillon R, Verstuyf A.
    J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
    [Abstract] [Full Text] [Related]

  • 22. The unique action for bone metabolism of 1 alpha,25-(OH)2D3-26,23-lactone.
    Kiyoki M, Kurihara N, Ishizuka S, Ishii S, Hakeda Y, Kumegawa M, Norman AW.
    Biochem Biophys Res Commun; 1985 Mar 15; 127(2):693-8. PubMed ID: 3838477
    [Abstract] [Full Text] [Related]

  • 23. 1,25-Dihydroxyvitamin D3 inhibits synthesis and enhances degradation of proteoglycans in osteoblastic cells.
    Takeuchi Y, Matsumoto T, Ogata E, Shishiba Y.
    J Biol Chem; 1989 Nov 05; 264(31):18407-13. PubMed ID: 2808381
    [Abstract] [Full Text] [Related]

  • 24. Cooperation of synthetic insulin-like growth factor I/somatomedin C and 1,25-dihydroxyvitamin D3 on regulation of function in clonal osteoblastic cells.
    Kurose H, Seino Y, Yamaoka K, Tanaka H, Shima M, Yabuuchi H.
    Bone Miner; 1989 Mar 05; 5(3):335-45. PubMed ID: 2720200
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. 17 beta-oestradiol enhances the stimulatory effect of 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity in human osteosarcoma SaOS-2 cells in a differentiation-dependent manner.
    Rao LG, Wylie JN, Kung Sutherland MS, Murray TM.
    J Endocrinol; 1996 Jan 05; 148(1):181-7. PubMed ID: 8568466
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Temperature-dependent alteration of 1,25-dihydroxy-vitamin D3 receptor macromolecules in MC3T3-E1 cells: affinity of hexafluoro analog of 1,25-dihydroxyvitamin D3, ST-630, for these forms.
    Tanaka M, Muramatsu M, Higuchi S, Otomo S.
    Res Commun Mol Pathol Pharmacol; 1994 Jul 05; 85(1):3-13. PubMed ID: 7953192
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. 1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] increases insulin-like growth factor I (IGF-I) receptors in clonal osteoblastic cells. Study on interaction of IGF-I and 1,25-(OH)2D3.
    Kurose H, Yamaoka K, Okada S, Nakajima S, Seino Y.
    Endocrinology; 1990 Apr 05; 126(4):2088-94. PubMed ID: 2156680
    [Abstract] [Full Text] [Related]

  • 36. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses.
    Chen TL, Hauschka PV, Cabrales S, Feldman D.
    Endocrinology; 1986 Jan 05; 118(1):250-9. PubMed ID: 3000737
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Stanniocalcin 1 and 1,25-dihydroxyvitamin D3 cooperatively regulate bone mineralization by osteoblasts.
    Kim JH, Kim K, Kim I, Seong S, Koh JT, Kim N.
    Exp Mol Med; 2024 Sep 05; 56(9):1991-2001. PubMed ID: 39218976
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.